INmune Bio Inc
NASDAQ:INMB

Watchlist Manager
INmune Bio Inc Logo
INmune Bio Inc
NASDAQ:INMB
Watchlist
Price: 1.73 USD -2.26% Market Closed
Market Cap: 46m USD

Wall Street
Price Targets

INMB Price Targets Summary
INmune Bio Inc

Wall Street analysts forecast INMB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INMB is 5.36 USD with a low forecast of 2.02 USD and a high forecast of 8.4 USD.

Lowest
Price Target
2.02 USD
17% Upside
Average
Price Target
5.36 USD
210% Upside
Highest
Price Target
8.4 USD
386% Upside
INmune Bio Inc Competitors:
Price Targets
600201
Jinyu Bio-Technology Co Ltd
40% Downside
ALEC
Alector Inc
44% Upside
RPTX
Repare Therapeutics Inc
19% Upside
ASMB
Assembly Biosciences Inc
45% Upside
NVAX
Novavax Inc
91% Upside
NIOX
Niox Group PLC
23% Upside
XFOR
X4 Pharmaceuticals Inc
81% Upside
IKT
Inhibikase Therapeutics Inc
186% Upside

Revenue
Forecast

Revenue Estimate
INmune Bio Inc

The compound annual growth rate of INmune Bio Inc's revenue for the next 4 years is 589%.

N/A
Past Growth
589%
Estimated Growth
Estimates Accuracy
31%
Average Beat

Operating Income
Forecast

Operating Income Estimate
INmune Bio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
INmune Bio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-40%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INMB's stock price target?
Price Target
5.36 USD

According to Wall Street analysts, the average 1-year price target for INMB is 5.36 USD with a low forecast of 2.02 USD and a high forecast of 8.4 USD.

What is INmune Bio Inc's Revenue forecast?
Projected CAGR
589%

The compound annual growth rate of INmune Bio Inc's revenue for the next 4 years is 589%.

Back to Top